Coamplification of HIV-1 proviral DNA and viral RNA in assays used for quantification of HIV-1 RNA.
Wan H, Seth A, Rainen L, Fernandes H
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of collection and storage tube type on HIV load determination in plasma using a Roche COBAS Amplicor HIV-1 Monitor version 1.5. From each patient, blood was collected into EDTA vacutainers and PPT tubes and centrifuged within 2 h as appropriate. After centrifugation, EDTA-plasma was transferred to a new tube before freezing at -70 degrees C, while plasma in the PPT was frozen at -70 degrees C in the collection tube.
Summary of Findings
While all 50 specimens collected and stored in PPT had detectable HIV loads, 14 of the 50 matched EDTA-plasma specimens had viral loads below the limit of detection. Further, the mean viral load in the 28 specimens with viral loads of 50-1000 copies/mL was 419 copies/mL in EDTA-plasma and 815 copies/mL in plasma collected and stored in PPTs (p=0.002). After destruction of the RNA through heat inactivation, 77% of HIV load was still detected in EDTA-plasma, and 58% was still detected in PPT tubes. After DNAse I treatment 93.7% of the viral load was detected in EDTA-plasma and 59.9% of the viral load was still detected in PPT tubes, indicating DNA is contributing to viral load determination in a collection tube-dependent manner. There were no differences in genomic DNA concentrations between EDTA-plasma and plasma collected and stored in PPT tubes.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
AIDS/HIV-relatedPlatforms
RNART-PCRDNAPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Biomarker level 1000-2500 copies HIV-1/mL3000-5000 copies HIV-1/mL50-1000 copies HIV-1/mL<50 copies HIV-1/mLBiospecimen Acquisition Type of collection container/solution EDTA vacutainerPPTStorage Type of storage container New tubePPT tubeAnalyte Extraction and Purification Nucleic acid digestion DNAseHeat-treatmentNone